Effects of melatonin on the quality of life in patients with delayed sleep phase syndrome

Journal of Psychosomatic Research

Volumn 48, Issue 1, 2000, Pages 45-50

  Nagtegaal, J E ^a   Laurant, M W ^b   Kerkhof, G A ^c   Smits, M G ^a   Van Der Meer, Y G ^a   Coenen, A M L ^b  

^a GELDERSE VALLEI HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Delayed sleep phase syndrome; Melatonin; Quality of life

Indexed keywords

MELATONIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED SLEEP PHASE SYNDROME; DRUG EFFECT; FEMALE; HUMAN; MALE; QUALITY OF LIFE; SLEEP DISORDER; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MELATONIN; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SALIVA; SLEEP DISORDERS, CIRCADIAN RHYTHM;

EID: 0034049395     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3999(99)00075-6     Document Type: Article

References (44)

1. Weitzman E.D., Czeisler C.A., Coleman R.M., Spielman A.J., Zimmerman J.C., Dement W. Delayed sleep phase syndrome, a chronobiological disorder with sleep-onset insomnia. Arch Gen Psychiatry. 38:1981;737.
2. Aldrich M.S. Sleep disorders 1. Neurol Clin. 14:1996;651-670.
3. Regestein Q.R., Monk T.H. Delayed sleep phase syndrome. a review of its clinical aspects Am J Psychiatry. 152:1995;602-608.
4. Dahlitz M., Alvarez B., Vignau J., English J., Arendt J., Parkes J.D. Delayed sleep phase syndrome response to melatonin. Lancet. 337:1991;1121-1124.
5. Tzischinsky O., Dagan Y., Lavie P. The effects of melatonin on the timing of sleep in patients with delayed sleep phase syndrome. Touitou Y., Arendt J., Pévet P. Melatonin and the pineal gland. From basic science to clinical application. 1993;351-354 Elsevier, Amsterdam.
6. Lewy A.J., Sack R.L. The dim light melatonin onset as a marker for circadian phase position. Chronobiol Int. 6:1989;93-102.
7. Lewy A.J., Ahmed S., Latham Jackson J.M., Sack R.L. Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int. 9:1992;380-392.
8. Nagtegaal J.E., Kerkhof G.A., Smits M.G., van der Meer Y.G., Swart A.C.W. Endogenous melatonin production and body temperature before and after treatment with melatonin in patients with delayed sleep phase syndrome. Chronobiol Int. 13(suppl 1):1996;96.
9. Van der Zee K., Sanderman R., Heyink J. De psychometrische kwaliteiten van de MOS 36-item Short Form Health Study (SF-36) in een Nederlandse populatie. Tijdschrift voor de sociale Gezondheidszorg. 71:1993;183-191.
10. Osterhaus J.T., Townsend R.J., Gandek B., Ware J.E. Measuring the functional status and well-being of patients with migraine headache. Headache. 34:1994;337-343.
11. Jenkinson C., Stradling J., Petersen S. Comparison of three measures of quality of life outcome in the evaluation of continuous positive airways pressure therapy for sleep apnoea. J Sleep Res. 6:1997;199-204.
12. Diagnostic and coding manual. 1990;128-133 Allen Press Inc, Lawrence, KS.
13. Iguchi H., Kato K.I., Ibayashi I. Melatonin serum levels and metabolic clearance rate in patients with liver cirrhosis. J Clin Endocrinol Metab. 54:1982;1025-1027.
14. Steindl P.E., Finn B., Bendok B., Rothke S., Zee P.C., Blei A.T. Disruption of the diurnal rhythm of plasma melatonin in cirrhosis. Ann Intern Med. 123:1995;274-277.
15. Viljoen M., Steyn M.E., Van Rensburg B.W.J., Reinach S.G. Melatonin in chronic renal failure. Nephron. 60:1992;138-143.
16. Dollins A.B., Zhdanova I.V., Wurtman R.J., Lynch H.J., Deng M.H. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, bodytemperature and performance. Proc Natl Acad Sci. 91:1994;1824-1828.
17. Carman J.S., Post R.M., Buswell R., Goodwin F.K. Negative effects of melatonin on depression. Am J Psychiatry. 133:1976;1181-1186.
18. Minors D.S., Waterhouse J.M. The use of constant routines in unmasking the endogenous component of human circadian rhythms. Chronobiol Int. 1:1984;205-216.
19. Nagtegaal J.E., Peeters A.B.H., Swart A.C.W., Smits M.G., Kerkhof G.A., van der Meer Y.G. Correlation between concentrations of melatonin in saliva and serum in patients with delayed sleep phase syndrome. Ther Drug Monit. 20:1998;181-183.
20. Nagtegaal J.E., Kerkhof G.A., Smits M.G., Swart A.C.W., van der Meer Y.G. Delayed sleep phase syndrome. a placebo controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset J Sleep Res. 7:1998;135-143.
21. Tarlov A.R., Ware J.E., Greenfield S., Nelson E.C., Perrin E., Zubkoff M. The Medical Outcomes Study. an application of methods for monitoring the results of medical care JAMA. 262:1989;925.
22. Van der Zee K., Sanderman R. Het meten van de algemene gezondheidstoestand met de RAND-36. 1993;NCG, Groningen. Een handleiding.
23. Van der Zee K., Sanderman R., Heyink J. A comparison of two multidimensional measures of health status. the Nottingham Health Profile and the RAND 36-item Health Survey 1.0 Qual Life Res. 5:1996;165-174.
24. Kazis L.E., Anderson J.J., Meenan R.F. Effect sizes for interpreting changes in health status. Med Care. 27(suppl):1989;S178-S189.
25. Cohen J. Statistical power for the behavioral sciences. 1977;Academic Press, New York.
26. Peck C., Coleman G. Implications of placebo theory for clinical research and practice in pain management. Theor Med. 12:1991;247-270.
27. Smith I.E., Shneerson J.M. Is the SF36 sensitive to sleep disruption? A study in subjects with sleep apnoea. J Sleep Res. 4:1995;183-188.
28. Chilot L.A., Shapiro C.M. The socio-economic impact of insomnia. An overview. Pharmacoeconomics. 10(suppl):1996;1-14.
29. Shapiro C.M., Dement W.C. Impact and epidemiology of sleep disorders. BMJ. 306:1993;1604-1607.
30. Wingard D.L., Berkman L.F. Mortality risk associated with sleeping patterns among adults. Sleep. 6:1983;102-107.
31. Nagtegaal J.E., Van Delft J.L., Bodelier V.M.W., Van Sorge A.A., Van Haeringen N.J. Melatonin inhibits cyclooxygenase-1 in the bovine iris/ciliary body. Ophthalmol Res. 29(suppl 1):1997;52.
32. Leach C.M., Thorburn G.D. A comparison of the inhibitory effects of melatonin and indomethacin on platelet aggregation and thromboxane release. Prostaglandins. 20:1980;51-56.
33. Goodman and Gilman's the pharmacological basis of therapeutics, 8th ed. In: Goodman X, Gilman A, Rall TW, Nies AS, Palmer T, eds. New York: Pergamon Press 1990.
34. Nagtegaal J.E., Smits M.G., Swart A.C.W., Kerkhof G.A., van der Meer Y.G. Melatonin responsive headache in delayed sleep phase syndrome. Preliminary observations. Headache. 38:1998;303-307.
35. Regestein Q.R., Pavlova M. Treatment of delayed sleep phase syndrome. Gen Hosp Psychiatry. 17:1995;335-345.
36. Globus G.C. A syndrome associated with sleeping late. Psychosom Med. 31:1969;528-539.
37. Surridge D.M., McLean A., Coulter M.E., Knowles J.B. Mood change following an acute delay of sleep. Psychiatry Res. 22:1987;149-158.
38. Wehr T.A., Wirz-Justice A., Goodwin F.K., Duncan W., Gillin J.C. Phase advance of the circadian sleep-wake cycle as an antidepressant. Science. 206:1979;710-713.
39. Goodwin F.K., Wirz-Justice A., Wehr T.A. Evidence that the pathophysiology of depression and the mechanism of action of antidepressant drugs both involve alterations in circadian rhythms. Costa E., Racagni G. Typical and atypical antidepressants. clinical practice:1982;1-12 Raven Press, New York.
40. Monk T.H. Biological rhythms and depressive disorders. Man J.J., Kupfer D.J. Biology of depressive disorders. Part A. A systems perspective:1993;103-122 Plenum Press, New York.
41. Dacourt G., Souetre E., Pringuey D., Robert P., Feuillade P., Belugou J.L. Disorders of circadian rhythms in depression. Encephale. 18(suppl 4):1992;473-478.
42. Ford D.E., Kamerow D.B. Epidemiologic study of sleep disturbances and psychiatric disorders. an opportunity for prevention? JAMA. 262:1989;1479-1484.
43. Kales A., Vgontzas A.N. Predisposition to and development and persistence of chronic insomnia. importance of psychobehavioral factors Arch Intern Med. 152:1992;1570-1572.
44. Smits M.G., Nagtegaal J.E., Kerkhof G.A. Melatonin in delayed sleep phase syndrome. Chronobiol Int. 14(suppl 1):1997;159.